The Biomarkers Shared Resource (BSR) is a joint resource of the Herbert Irving Comprehensive Cancer Center (HICCC) and Columbia?s National Institute of Environmental Health Sciences Center for Environmental Health. Directed by Regina Santella, PhD, the BSR provides a centralized, efficient, and cost-effective resource for receiving, processing, storing, inventorying and shipping human samples that are collected as part of research studies in molecular epidemiology and clinical cancer-related research. In addition, the BSR carries out biomarker profiling across multiple nucleic acid-based and protein-based assay platforms. Services provided include: (1) consultation on sample collection and processing, (2) preparation of kits for biospecimen collection, (3) processing and storage of blood components including cells and plasma, (4) storage of other body fluids, (5) isolation of DNA/RNA with quality controls; (6) maintenance of a sample inventory that tracks each vial and its contents, and (7) analysis of samples for a wide array of biomarkers using nucleic acid-based (DNA single nucleotide polymorphism [SNP] genotyping, DNA methylation profiling, and microRNA and mRNA expression) and protein-based (ELISA) assay platforms. The readily accessible, high-quality, affordable and high value services make the BSR a broadly used and highly cost-effective facility. Consultation is provided on all aspects of sample collection and processing for specific studies including sample collection, shipment methods, standard operating procedures for separation of specific blood fractions and aliquoting. In addition, the BSR stores tissue sections from tumor/adjacent tissues on microscope slides processed in collaboration by the Molecular Pathology Shared Resource. Coded samples are received by the facility and processed into appropriate fractions (e.g., serum, plasma, mononuclear cells, granulocytes, total white blood cells and red blood cells) and frozen in multiple aliquots distributing them into multiple freezers. A web-based database of the sample inventory is maintained and samples are retrieved following specific governing protocols as required by individual studies. Analytical services include genotyping for SNPs in candidate genes, analysis of DNA methylation and gene and microRNA expression. The BSR also supports quantitative testing of a wide number of biomarkers analyzed by ELISA. Samples from over 70,000 subjects participating in 145 different studies (of which 110 cancer relevant) are currently stored. The BSR will continue to provide state-of-the-art sample processing, storage, and analysis enabling HICCC members in the conduct of cutting-edge research. During the current project period (2014- 2019), the BSR was utilized by 56 HICCC members, (33% of entire membership), supported key data for 102 peer-reviewed publications including 12 papers in high impact journals (impact factor >10) and publications in reference cancer and cancer epidemiology journals such as British Journal of Cancer, JAMA Network Open, and Cancer Epidemiol Biomarkers & Prevention. The BSR currently supports research in 11 NIH-funded research grants (seven of which are NCI grants).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA013696-45
Application #
10022764
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-07-04
Project End
2025-06-30
Budget Start
2020-07-01
Budget End
2021-06-30
Support Year
45
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Columbia University (N.Y.)
Department
Type
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Proto, Jonathan D; Doran, Amanda C; Subramanian, Manikandan et al. (2018) Hypercholesterolemia induces T cell expansion in humanized immune mice. J Clin Invest 128:2370-2375
Shang, Enyuan; Zhang, Yiru; Shu, Chang et al. (2018) Dual Inhibition of Bcl-2/Bcl-xL and XPO1 is synthetically lethal in glioblastoma model systems. Sci Rep 8:15383
Shen, Megan Johnson; Prigerson, Holly G; Ratshikana-Moloko, Mpho et al. (2018) Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South Africa. J Glob Oncol :1-9
Apatoff, Mary Ben L; Sengillo, Jesse D; White, Eugenia C et al. (2018) Autologous stem cell therapy for inherited and acquired retinal disease. Regen Med 13:89-96
Billing, David; Horiguchi, Michiko; Wu-Baer, Foon et al. (2018) The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection. Mol Cell 72:127-139.e8
Connors, Thomas J; Baird, J Scott; Yopes, Margot C et al. (2018) Developmental Regulation of Effector and Resident Memory T Cell Generation during Pediatric Viral Respiratory Tract Infection. J Immunol 201:432-439
Brescia, Paola; Schneider, Christof; Holmes, Antony B et al. (2018) MEF2B Instructs Germinal Center Development and Acts as an Oncogene in B Cell Lymphomagenesis. Cancer Cell 34:453-465.e9
Wu, Hui-Chen; Do, Catherine; Andrulis, Irene L et al. (2018) Breast cancer family history and allele-specific DNA methylation in the legacy girls study. Epigenetics 13:240-250
Sitko, Austen A; Kuwajima, Takaaki; Mason, Carol A (2018) Eye-specific segregation and differential fasciculation of developing retinal ganglion cell axons in the mouse visual pathway. J Comp Neurol 526:1077-1096
Tzoneva, Gannie; Dieck, Chelsea L; Oshima, Koichi et al. (2018) Clonal evolution mechanisms in NT5C2 mutant-relapsed acute lymphoblastic leukaemia. Nature 553:511-514

Showing the most recent 10 out of 331 publications